Navigation Links
AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market
Date:1/29/2009

Company announces implementation of Kingdee enterprise accounting system across its US & China-based operations

TUSTIN, Calif., Jan. 29 /PRNewswire-FirstCall/ -- AMDL, Inc. (NYSE Alternext US: ADL), a vertically integrated pharmaceutical company with operations in China and the US, announced today it is implementing a state-of-the-art, westernized enterprise accounting system across its US and China-based operations.

Developed by China-based Kingdee International Software, the new accounting system runs on a high-speed, point-to-point dedicated server system to completely streamline end-to-end accounting practices, financial reporting, taxation, corporate governance and controls to deliver real-time financials. The accounting system has already been implemented in AMDL's US-based headquarters and implementation across the Company's China-based pharmaceutical operations underway.

Over the past four years AMDL has seen over 100% year-over-year growth and anticipates continuing this trend for fiscal year 2009 where it is once again forecasting at least 100% sales growth. Management's decision to implement the new Kingdee accounting system is an instrumental part of the Company's plan to increase financial transparency, manage and run all operations on a real time basis, based on best business practices and standards.

According to AMDL's Chairman and CEO, Mr. Douglas MacLellan, "This implementation represents Kingdee's first US technology deployment, making AMDL the only China-based, US publicly-traded Company to operationalize an accounting system that meets the demanding and rigorous requirements of US GAAP-certified accounting standards. We took a very cost-effective and diligent approach in choosing Kingdee and we believe the system gives AMDL internal controls financially and operationally over our Chinese company publicly listed on a US exchange."

With more th
'/>"/>

SOURCE AMDL, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009
2. Worlds first mandatory national nanotech rule pending
3. Medarex Announces Allowance of Investigational New Drug Application for Companys First Antibody-Drug Conjugate, MDX-1203
4. Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
5. International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"
6. AMDL, Inc. Announces 2009 Financial Guidance and First Quarter Business Objectives
7. Australian Authorities (TGA) First to Grant Final Product Approval for Intercells Vaccine to Prevent Japanese Encephalitis
8. MultiVu Video Feed: Geron Receives FDA Clearance to Begin Worlds First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
9. ScienceFirst Staff Expansion
10. Varian, Inc. Announces First Quarter 2009 Preliminary Results
11. Verenium Announces First Commercial Cellulosic Ethanol Project

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...wire/ -- EUCODIS Bioscience, a company,developing,... for the,chemical industry announced today that it...dus, the leading biopharmaceutical company in Lati...Bioscience exclusive access - for the search,of en...ection of,psychrophilic bacteria strains and other...
(Date:11/6/2009)...re/ -- Calbiotech, Inc. announced today that it ha...h (SBIR) Phase I contract by the U.S. Army Medical... agreement, Calbiotech will develop analyte specif...us. ,, Dengue virus is a mosquito-born flavi...orces deployed to tropical areas of the world. Due...
(Date:11/6/2009)... Intarcia Therapeutics, Inc. delivered two present...us delivery of exenatide) program for the treatmen...Technology Meeting in San Francisco, CA: ,, (Lo...SFTU126LOGO ) ,, Continuous Subcutaneous Deli...se, HbA1c and Reduces Weight in a 28-day Phase 1b ...
(Date:11/5/2009)... Fuel economy ratings for the new 2010 model year...y.gov web site, which Oak Ridge National Laborato... of Energy and the U.S. Environmental Protection A...l economy list are hybrid electrics, led by the To...roves that hybrids have gone mainstream," said pro...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...- Third Quarter 2007 Financial Results and Busines...0 a.m. Eastern Time -, OAKLAND, Calif., Nov. 14 ..., a developer of mechanical circulatory,support sy...l results and,host a presentation of the results a....m. Pacific / 11:30 a.m. Eastern time on November,...
...MELBOURNE, Australia, Nov. 14 Swiss experts have,...st (TST) favouring the,use of interferon-a release...or screening patients for tuberculosis (TB) infect...h as anti-TNF-a therapy). In recommendations,publi...kly, experts,advocate the use of QFT(TM) in place ...
...NEW HAVEN, CT, and TORONTO, Nov. 13 /PRNewswire/ -...nt of RiboSwitch based therapeutic agents and,Dalt...esearch collaboration,to discover new therapeutics...roprietary insights to,design and synthesize sever...oSwitch targets. BioRelix will advance these compo...
Other Biology Technology:Swiss Experts Recommend QuantiFERON(R)-TB Gold for Tuberculosis Infection Screening Prior to Initiating anti-TNF-a Therapy 2Swiss Experts Recommend QuantiFERON(R)-TB Gold for Tuberculosis Infection Screening Prior to Initiating anti-TNF-a Therapy 3BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology 2
(Date:11/5/2009)...archers at Yale University have developed syntheti... response to HIV and HIV-infected cells, as well a...hed online in the Journal of the American Chemica...ches for these diseases. , The molecules calle...M-H) and "antibody-recruiting molecule targeting p...
(Date:11/4/2009)...in natural science) , United States Using Less...r today than it did 35 years ago, despite a 30 per...e partly attributable to alternative cooling metho...ystems. According to the latest USGS water use rep...tates goes to cooling thermoelectric power plants....
(Date:11/4/2009)...y bacteria, it turns out, hold the power to help m...d the world clean up toxic waste on test sites. ,... were invented back in World War II and have been ...h-energy compounds are often used to propel tank s... , But with increased knowledge of their envir...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Genomic research will enable greener cleanup of military explosive test sites 2Wildfires set to increase 50 percent by 2050 9392 1Wildfires set to increase 50 percent by 2050 9392 2Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 1Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 2Gloomy Days Dim Cognitive Powers of the Depressed 52961 1Gloomy Days Dim Cognitive Powers of the Depressed 52961 2
..., London, UK, 9 June 2008 Elsevier, a world-lead... information products and services, is pleased to ...( http://www.sciencedirect.com/science/journal/175...opics throughout the life sciences. , The aim of ... work that is interesting and challenging, and pro...
..., This release is available in Spanish . , , ...to monitor radioactivity levels in the environment...ended by Ms Natalia Alegra at the University of ...gy for distinguishing between natural radioactivit... Most countries currently have radiological monit...
..., (PHILADELPHIA) A clinical study on patients wh...lly purified extract of Chinese red yeast rice, Xu...ttacks by 45%, revascularization (bypass surgery/a...rtality by one-third and cancer mortality by two-t...tudy, was conducted on almost 5,000 patients, rang...
Other Biology News:Elsevier launches Bioscience Hypotheses 2More sensitive radiology monitoring in the Basque Country 2More sensitive radiology monitoring in the Basque Country 3Study finds Chinese food good for your heart 2
RNase H from Roche Applied Science
T4 DNA Ligase (HC) from Invitrogen
Sheep Anti-Bovine BETA-LACTOGLOBULIN A Polyclonal Antibody, Unconjugated from AbD Serotec
Rabbit Anti-Somatostatin 28 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: